Mutations in the NF-kappaB signaling pathway: implications for human disease (Q34577553)

3 August 2017

1 reference

title

Mutations in the NF-kappaB signaling pathway: implications for human disease (English)

1 reference

3 August 2017

0 references

Courtois G

1

1 reference

3 August 2017

Gilmore TD

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

3 August 2017

1 reference

3 August 2017

25

1 reference

3 August 2017

6831-6843

1 reference

3 August 2017

51

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209939

3 August 2017

0 references

cites work

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Identification of the familial cylindromatosis tumour-suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Combined functional genomic maps of the C. elegans DNA damage response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Ubiquitin signalling in the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Genetics of Paget's disease of bone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Identification and characterization of p100HB, a new mutant form of p100/NF-κB2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Large B-cell lymphoma with Hodgkin's features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Evidence that BCL3 plays a role in the etiology of nonsyndromic oral clefts in Brazilian families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Genomic organization and expression of the rearranged REL proto-oncogene in the human B-cell lymphoma cell line RC-K8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A polymorphism in the TNF-alpha promoter gene is associated with pediatric onset and colonic location of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Ectodysplasin signaling in development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Immunological adjuvants promote activated T cell survival via induction of Bcl-3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Pyogenic bacterial infections in humans with IRAK-4 deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Negative regulation of JNK signaling by the tumor suppressor CYLD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Mining for regulatory programs in the cancer transcriptome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Sequence homologies between four cytoskeleton-associated proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Two novel somatic mutations in the human interleukin 6 promoter region in a patient with sporadic breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

NEMO/IKK gamma-deficient mice model incontinentia pigmenti.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Lymphoid malignancies: the dark side of B-cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

NF-kappaB-related genetic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Splenic small B-cell lymphoma with IGH/BCL3 translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Signalling pathways and molecular interactions of NOD1 and NOD2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

IRAK-4 as the central TIR signaling mediator in innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

New genes involved in cancer identified by retroviral tagging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Mutational analysis of the IkappaBalpha gene in activated B cell-like diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

CATERPILLERs, pyrin and hereditary immunological disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Recurrent 'sterile' verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Identification of a tumor-associated mutant form of the NF-kappaB RelA gene with reduced DNA-binding and transactivating activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Immune regulation by SLAM family receptors and SAP-related adaptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Ubiquitin and ubiquitin-like proteins as multifunctional signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Identification of the cylindromatosis tumor-suppressor gene responsible for multiple familial trichoepithelioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

CYLD mutation causes multiple familial trichoepithelioma in three Chinese families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209939

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209939

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference